Global specialty pharmaceutical company focusing on central nervous system (CNS), gastrointestinal (GI), and renal diseases. Based in Chineham, England. (Nasdaq: SHPGY)
Discovers, develops, manufactures and markets isoflavonoids for menopausal non-prescription drugs, and multiple signal transduction regulator drugs for cancer. Includes technological overview, and history of company, with offices in Europe and North America, and headquarters in North Ryde, New South Wales. (Nasdaq: NVGN)
Developing therapies for neurological disorders such as spinal cord injuries, neurodegenerative diseases and glaucoma. Features explanation of technology and details of clinical studies. Los Angeles, California, USA.
A research and development company offering analytical, preformulation, formulation and stability testing services to the pharmaceutical and biotechnology industries.
Specializes in combining inhibitors of bacterial resistance with proven antibiotics to treat serious infections. Based in San Diego, California.
Custom research organization specializing in synthesis of organic compounds, process and drug development and GMP manufacturing of pharmaceuticals and fine organic chemicals.
Develops novel metalloporphyrin therapeutics for the treatment of cancer and neurodegenerative diseases. Includes clinical trail for amyotrophic lateral sclerosis, investor details, and publications from Greenwood Village, Colorado.
Pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines for healthcare.
Biopharmaceutical company focused on the development of therapeutic and diagnostic products using genomic and proteomic technologies. Services include drug discovery, gene discovery and genetic testing.
Provides contract research services to pharmaceutical and biotech companies, in the areas of chemistry, formulations, pre-clinical pharmabiology, and bioanalytical studies. Based in India.
|